|
|
Blood, 1 September 2008, Vol. 112, No. 5, pp. 2101-2110.
Prepublished online as a Blood First Edition Paper on July 2, 2008; DOI 10.1182/blood-2007-12-126987.
Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease
Tangsheng Yi13,
Dongchang Zhao2,3,
Chia-Lei Lin2,3,
Chunyan Zhang2,3,
Ying Chen2,3,
Ivan Todorov2,
Thomas LeBon1,
Fouad Kandeel2,
Stephen Forman3, and
Defu Zeng13
1 Graduate School of Biological Science,
2 Department of Diabetes, Endocrinology & Metabolism, and
3 Division of Hematology & Hematopoietic Cell Transplantation, The Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
Th17 is a newly identified T-cell lineage that secretes proinflammatory cytokine IL-17. Th17 cells have been shown to play a critical role in mediating autoimmune diseases such as EAE, colitis, and arthritis, but their role in the pathogenesis of graft-versus-host disease (GVHD) is still unknown. Here we showed that, in an acute GVHD model of C57BL/6 (H-2b) donor to BALB/c (H-2d) recipient, IL-17–/– donor T cells manifested an augmented Th1 differentiation and IFN- production and induced exacerbated acute GVHD. Severe tissue damage mediated by IL-17–/– donor T cells was associated with increased Th1 infiltration, up-regulation of chemokine receptors by donor T cells, and enhanced tissue expression of inflammatory chemokines. Administration of recombinant IL-17 and neutralizing IFN- in the recipients given IL-17–/– donor cells ameliorated the acute GVHD. Furthermore, the regulation of Th1 differentiation by IL-17 or Th17 may be through its influence on host DCs. Our results indicate that donor Th17 cells can down-regulate Th1 differentiation and ameliorate acute GVHD in allogeneic recipients, and that treatments neutralizing proinflammatory cytokine IL-17 may augment acute GVHD as well as other inflammatory autoimmune diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Socie and B. R. Blazar
Acute graft-versus-host disease: from the bench to the bedside
Blood,
November 12, 2009;
114(20):
4327 - 4336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yi, Y. Chen, L. Wang, G. Du, D. Huang, D. Zhao, H. Johnston, J. Young, I. Todorov, D. T. Umetsu, et al.
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
Blood,
October 1, 2009;
114(14):
3101 - 3112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, R. Das, R. Komorowski, A. Beres, M. J. Hessner, M. Mihara, and W. R. Drobyski
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
Blood,
July 23, 2009;
114(4):
891 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. von Vietinghoff and K. Ley
IL-17A Controls IL-17F Production and Maintains Blood Neutrophil Counts in Mice
J. Immunol.,
July 15, 2009;
183(2):
865 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
J. Exp. Med.,
July 6, 2009;
206(7):
1457 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, W. Asavaroengchai, B. Yong Yeap, M.-G. Wang, S. Wang, M. Sykes, and Y.-G. Yang
Paradoxical effects of IFN-{gamma} in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury
Blood,
April 9, 2009;
113(15):
3612 - 3619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Carlson, M. L. West, J. M. Coghill, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Blood,
February 5, 2009;
113(6):
1365 - 1374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Li, Y. Chen, W. He, T. Yi, D. Zhao, C. Zhang, C.-L. Lin, I. Todorov, F. Kandeel, S. Forman, et al.
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI
Blood,
January 22, 2009;
113(4):
953 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Kappel, G. L. Goldberg, C. G. King, D. Y. Suh, O. M. Smith, C. Ligh, A. M. Holland, J. Grubin, N. M. Mark, C. Liu, et al.
IL-17 contributes to CD4-mediated graft-versus-host disease
Blood,
January 22, 2009;
113(4):
945 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lee, P. Wang, M. G. Kattah, S. Youssef, L. Steinman, K. DeFea, and D. S. Straus
Differential Regulation of Chemokines by IL-17 in Colonic Epithelial Cells
J. Immunol.,
November 1, 2008;
181(9):
6536 - 6545.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|